Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • corona virus

Tag: corona virus

  • BiotechToday
  • World

Are Care Home Residents more vulnerable to SARS-CoV-2?

bioxone March 8, 2021March 8, 2021

-Devyani Goswami, Amity University Kolkata One of the parts of the society which remains under huge threat for the spreading of the deadly SARS-CoV-2 is the care homes. Older people with health issues remain to be the vulnerable target of this virus. The shared living accommodations along with residents, staff and visitors in an enclosed […]

Read More
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020 2

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Read More
  • BiotechToday
  • World

Moderna requests emergency authorization from FDA for mRNA – 1273

bioxone December 1, 2020December 1, 2020 1

Prama Ghosh, Amity University Kolkata The Cambridge, Massachusetts – based Biotech Company, Moderna asked for emergency authorization from the U.S. Food and Drug Administration to use its COVID – 19 vaccines, mRNA – 1273, after receiving confirmation about its safety and efficacy on Monday. According to a new study, the shots offer a strong protection […]

Read More
  • BiotechToday
  • World

Comparison of Powersoil and MagMAX2

bioxone November 25, 2020November 25, 2020 2

Anannya Roy, Amity University Kolkata Microbial Ecology known as environmental microbiology is the study of microorganisms’ relationship with each other as well as their environment. The main goal of researchers in this department is to capture the maximum amount of information from all organisms that are present in a given sample. Traditionally DNA-based protocols are […]

Read More
  • BiotechToday
  • India

India set to begin the COVID-19 vaccination soon

bioxone November 7, 2020November 7, 2020 1

Prama Ghosh, Amity University Kolkata India is preparing to roll out COVID-19 vaccines with Anganwadi centres, schools, panchayat buildings and other such setups and buildings identified by the state governments as vaccination sites in addition to healthcare facilities. The anti-corona virus inoculation drive would be monitored by the Union health ministry’s digital platform and tracking […]

Read More
  • BiotechToday
  • World

Herd Immunity Theory? – A Warning!! From WHO

bioxone October 14, 2020October 14, 2020

Samrat Sarkar, Amity University Kolkata  On this point when the entire world is on its way to find a way out to find a solution of the CORONA virus, scientists came up with an idea of ‘Herd Immunity’ theory which according to them would have been a big hit but on the other way WHO’s […]

Read More
  • BiotechToday
  • World

Vitamin D significantly reduces Covid-19 mortality by 50%

bioxone September 27, 2020September 27, 2020

-Anuska Sen, Team bioXone It is a well-known fact to all of us that Vitamin D is indispensable in a healthy life. Not only does it help in maintaining proper bone formation and its structure, but it also aids to prevent skin cancer in people. One of the best, easiest and most reliable natural sources […]

Read More
  • World

COVID-19 is in our Brains now?

bioxone September 19, 2020September 19, 2020

-Sashreek Ganguli, Amity University Kolkata The manifestations of SARS-CoV-2 on various body systems are being thoroughly studied in this global pandemic. Amidst all the other systems which the virus affects, the nervous system is frequently involved in patients hospitalized with COVID-19. Neurological abnormalities were seen in 30% of hospitalized patients. It was discovered that certain […]

Read More
  • Biotechnopedia

Asymptomatic patients of COVID-19: threat to the population?

bioxone September 18, 2020September 18, 2020

-Anwesha Chatterjee, Amity University Kolkata The novel coronavirus is spreading rapidly throughout the world. It is impossible to restrict the spread of the SARS-CoV-2.  A huge proportion of the population across the world got infected and showed the most common to mild to serious symptoms (fever, dry cough, respiratory problems, conjunctivitis, aches, pains, rashes, and many more) along with the high […]

Read More
  • India

Indian Covaxin – One Step closer to success

bioxone September 18, 2020September 18, 2020 2

–Thota Kanishka Rao, Amity University Kolkata Hyderabad-based Bharat Biotech in a joint effort with analysts from the ICMR’s National Institute of Virology, based in Pune has delivered the information from the creature preliminaries of its immunization competitor. It demonstrated that Covaxin had the option to produce ‘robust immune responses. The two-portion vaccination routine of Covaxin […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy

Protected by Malware Removal